GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adastra Holdings Ltd (XCNQ:XTRX) » Definitions » ROE % Adjusted to Book Value

Adastra Holdings (XCNQ:XTRX) ROE % Adjusted to Book Value : -42.44% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Adastra Holdings ROE % Adjusted to Book Value?

Adastra Holdings's ROE % for the quarter that ended in Mar. 2024 was -37.35%. Adastra Holdings's PB Ratio for the quarter that ended in Mar. 2024 was 0.88. Adastra Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -42.44%.


Adastra Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Adastra Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adastra Holdings ROE % Adjusted to Book Value Chart

Adastra Holdings Annual Data
Trend Apr19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- -18.65 -6.44 -27.39 -25.64

Adastra Holdings Quarterly Data
Oct18 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.12 -22.42 -17.90 -45.98 -42.44

Competitive Comparison of Adastra Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Adastra Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adastra Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adastra Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Adastra Holdings's ROE % Adjusted to Book Value falls into.



Adastra Holdings ROE % Adjusted to Book Value Calculation

Adastra Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-21.54% / 0.84
=-25.64%

Adastra Holdings's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-37.35% / 0.88
=-42.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adastra Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Adastra Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Adastra Holdings Business Description

Traded in Other Exchanges
Address
275th Street, Suite 5451, Langley, BC, CAN, V4W 3X8
Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.
Executives
Lachlan Clyde Mcleod Senior Officer

Adastra Holdings Headlines

No Headlines